Bronchiectasis prevalence, incidence, and exacerbation rates among insured adults in the U.S.: a descriptive analysis.
Observed prevalence-incidence widening gap suggests case accumulation over time and survival among continuously enrolled beneficiaries, while exacerbation rates decreased over time across payers and subgroups, in part reflecting changes in cohort composition.